Eli Lilly's Alzheimer's drug Kisunla received FDA approval, but the stock didn't surge as expected due to the news being anticipated.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing
Eli Lilly's Alzheimer's drug Kisunla received FDA approval, but the stock didn't surge as expected due to the news being anticipated.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing
We are preparing, please wait
This content is only available for premium members. Please become a paid member to access.
Download AppCurrently, memberships can only be purchased through the app.